• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Healthcare·7713.TWO
Share

WeLeader Biomedical Co., Ltd. Stocks

NT$ 73Last Updated 19.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

NT$ 102.39M

NT$ 73
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

WeLeader Biomedical Co. Ltd. is primarily involved in the development and distribution of medical diagnostic instruments and related supplies. The company offers specialized products such as integrated systems for serum biochemistry, alongside comprehensive solutions for clinical care and the management of medical information. Established on April 28, 2003, its principal operations are based in Kaohsiung City, Taiwan.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

19.10.2026 20:13

Silence Therapeutics shares soared 125%. Merck is acquiring the cancer therapy developer

19.10.2026 18:43

"A buying opportunity is emerging": Nasdaq jumped 1% after the sell-off

19.10.2026 18:30

Analysts see 35% upside in label maker Brady on data center demand and Honeywell deal

19.10.2026 18:09

Goldman names 23 'unloved' defensive stocks as tech falters

19.10.2026 16:08

Morning in New York: Looking for a Foothold Ahead of Tech Giants' Earnings Reports

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026